TNSN08272A1 - Preparation of gamma-amino acids having affinity for the alpha-2-delta protein - Google Patents

Preparation of gamma-amino acids having affinity for the alpha-2-delta protein

Info

Publication number
TNSN08272A1
TNSN08272A1 TNP2008000272A TNSN08272A TNSN08272A1 TN SN08272 A1 TNSN08272 A1 TN SN08272A1 TN P2008000272 A TNP2008000272 A TN P2008000272A TN SN08272 A TNSN08272 A TN SN08272A TN SN08272 A1 TNSN08272 A1 TN SN08272A1
Authority
TN
Tunisia
Prior art keywords
alpha
preparation
gamma
affinity
amino acids
Prior art date
Application number
TNP2008000272A
Other languages
English (en)
Inventor
Margaret Claire Evans
Llyod Charles Franklin
Lorraine Michelle Murtagh
Thomas Norman Nanninga
Bruce Allen Pearlman
James Edward Saenz
Niamh Josephine Willis
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN08272A1 publication Critical patent/TNSN08272A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/002—Nitriles (-CN)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/005—Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

IL EST DECRIT DES MATIERES ET PROCEDES POUR LA PREPARATION DE ϒ - AMINOACIDES OPTIQUEMENT ACTIFS DE FORMULE I QUI SE RELENT A LA SOUS- UNITE ALPHA - 2- DELTA (α2ϭ) d un CANAL CALCIUM
TNP2008000272A 2005-12-21 2008-06-20 Preparation of gamma-amino acids having affinity for the alpha-2-delta protein TNSN08272A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75283905P 2005-12-21 2005-12-21
PCT/IB2006/003656 WO2007072159A1 (fr) 2005-12-21 2006-12-11 Preparation d’acides gamma-amines ayant une affinite pour la proteine alpha-2-delta

Publications (1)

Publication Number Publication Date
TNSN08272A1 true TNSN08272A1 (fr) 2009-10-30

Family

ID=37903526

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2008000272A TNSN08272A1 (fr) 2005-12-21 2008-06-20 Preparation of gamma-amino acids having affinity for the alpha-2-delta protein

Country Status (28)

Country Link
US (2) US20070141684A1 (fr)
EP (2) EP2017259A3 (fr)
JP (1) JP2009520492A (fr)
KR (1) KR20080068932A (fr)
CN (1) CN101341117A (fr)
AP (1) AP2008004485A0 (fr)
AR (1) AR058559A1 (fr)
AU (1) AU2006327872A1 (fr)
BR (1) BRPI0620467A2 (fr)
CA (1) CA2633358A1 (fr)
CR (1) CR10080A (fr)
DO (1) DOP2006000286A (fr)
EA (1) EA200801393A1 (fr)
EC (1) ECSP088551A (fr)
GT (1) GT200600524A (fr)
IL (1) IL191840A0 (fr)
MA (1) MA30139B1 (fr)
ME (1) ME00005B (fr)
NL (1) NL2000374C2 (fr)
NO (1) NO20082989L (fr)
NZ (1) NZ568971A (fr)
PE (1) PE20071169A1 (fr)
RS (1) RS20080279A (fr)
TN (1) TNSN08272A1 (fr)
TW (1) TW200736201A (fr)
UY (1) UY30031A1 (fr)
WO (1) WO2007072159A1 (fr)
ZA (1) ZA200804780B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110025917A (ko) * 2008-05-21 2011-03-14 산도즈 아게 ５－메틸－３－니트로메틸－헥산산 에스테르의 입체선택적 효소 가수분해 방법
WO2011144742A1 (fr) 2010-05-21 2011-11-24 Chemilia Ab Nouveaux dérivés de pyrimidine
FR2966734B1 (fr) * 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
AU2012230229A1 (en) 2011-03-24 2013-10-10 Noviga Research Ab Novel pyrimidine derivatives
CN102249833B (zh) * 2011-05-27 2013-12-11 中国科学院化学研究所 一种制备手性γ-氨基酸及其衍生物的方法
WO2017155025A1 (fr) * 2016-03-10 2017-09-14 第一三共株式会社 Procédé de production de dérivés optiquement actifs de l'acide valérique par résolution optique au moyen d'une enzyme
CN108192932B (zh) * 2017-12-26 2020-09-29 上海皓元生物医药科技有限公司 一种手性醇的酶催化制备方法
CN112877219A (zh) * 2021-01-29 2021-06-01 江西科技师范大学 一种高浓度胆固醇培养基及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5618710A (en) 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035298A1 (fr) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing-gum contenant des agents medicamenteux actifs
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
TR200103587T2 (tr) 1999-06-10 2002-04-22 Warner Lambert Company Mono-ve çift ikame edilmiş 3-propil gama aminobutirik asitler.
US6642398B2 (en) * 1999-06-10 2003-11-04 Warner-Lambert Company Mono-and disubstituted 3-propyl gamma-aminobutyric acids
CA2505788A1 (fr) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Derives de pregabalin pour le traitement de la fibromyalgie et d'autres troubles
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)

Also Published As

Publication number Publication date
UY30031A1 (es) 2007-07-31
NO20082989L (no) 2008-09-19
KR20080068932A (ko) 2008-07-24
EA200801393A1 (ru) 2009-12-30
EP2017259A3 (fr) 2011-04-13
WO2007072159B1 (fr) 2008-08-21
WO2007072159A1 (fr) 2007-06-28
ME00005B (fr) 2010-06-10
CR10080A (es) 2008-07-10
CN101341117A (zh) 2009-01-07
EP1973867A1 (fr) 2008-10-01
IL191840A0 (en) 2008-12-29
NZ568971A (en) 2010-04-30
BRPI0620467A2 (pt) 2011-11-16
AP2008004485A0 (en) 2008-06-30
NL2000374C2 (nl) 2010-02-09
MEP0708A (xx) 2010-02-10
US20090299093A1 (en) 2009-12-03
PE20071169A1 (es) 2007-11-30
GT200600524A (es) 2007-12-03
NL2000374A1 (nl) 2007-06-25
EP2017259A2 (fr) 2009-01-21
MA30139B1 (fr) 2009-01-02
AU2006327872A1 (en) 2007-06-28
JP2009520492A (ja) 2009-05-28
AR058559A1 (es) 2008-02-13
US20070141684A1 (en) 2007-06-21
DOP2006000286A (es) 2007-07-31
RS20080279A (en) 2009-07-15
ZA200804780B (en) 2009-05-27
TW200736201A (en) 2007-10-01
CA2633358A1 (fr) 2007-06-28
ECSP088551A (es) 2008-07-30

Similar Documents

Publication Publication Date Title
TNSN08272A1 (fr) Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
EA200802054A1 (ru) Ингибиторы фермента
EP1954137A4 (fr) 2-ceto-oxazoles en tant que modulateurs d'amide d'acide gras hydrolase
MA32729B1 (fr) Derives d'acide 1-amino-2-cyclobutylethylboronique
PE20090211A1 (es) Inhibidores de las iap
SV2003001103A (es) Formulaciones autoemulsionantes de inhibidores de la proteina de transferencia de colesteril ester pc10894
FR2920966B1 (fr) Procede capillaire comprenant l'application d'une polyamine et d'un acide gras
MX2009007266A (es) Formulaciones estables de acido s-(+)-abscisico liquidas y de granulo soluble.
IN2012CN10925A (fr)
DE602006013513D1 (de) Enzymatische herstellung von persäuren aus carbonsäureestersubstraten mittels nicht-häm-haloperoxidasen
EA200700702A1 (ru) Аналоги локсапина и способы их применения
UY27618A1 (es) Ésteres hidroxamato de ácido n-(4-fenil-sustituido)-antranílico
PA8563801A1 (es) Esteres hidroxamato del acido n-(4-fenil sustituido)- antranilico
FR2915381B1 (fr) Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c
HK1126086A1 (en) Application of fluorescent protein to horticultural plant
DE602004009030D1 (de) Phenyltetrazol-Verbindungen
DE602007012971D1 (de) Verfahren zur Herstellung von (Meth)Acrylsäure
ECSP045215A (es) Metabolitos del ácido (3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi) acético
WO2006101629A3 (fr) Variant d'epissage d'une sous-unite alpha de proteine type iii de canal sodique
BR0112245B1 (pt) Éster de ácido 4-alcóxi-ciclohexano-1-amino-carboxílico
MA30265B1 (fr) Procedes et compositions destines a cibler relt
FR2909280B1 (fr) Utilisation de l'acide gamma-aminobutyrique en tant qu'agent depigmentant
MA29036B1 (fr) Diamides d'acide n-heterocyclylphtalique utilises comme insecticide
ATE506069T1 (de) Verfahren und zusammensetzung zur modulation des systemischen entzündlichen reaktionssyndroms (sirs)
MA28996B1 (fr) Nouvelle utilisation de l'acide 2-hydroxy-4-methylthyiobutanoïque(hmte)